Literature DB >> 17278933

Pool exercise for individuals with fibromyalgia.

Susan E Gowans1, Amy deHueck.   

Abstract

PURPOSE OF REVIEW: The benefits of general aerobic exercise for individuals with fibromyalgia have been established. Recently, there have been a number of randomized controlled trials that evaluate the benefits of pool exercise for fibromyalgia. This review will integrate the results of eight pool exercise studies that have been published in the last 7 years. RECENT
FINDINGS: Pool exercise has been evaluated against sedentary control groups, land-based exercise and immersion in a warm, mineralized pool. Pool exercise has been shown to be as effective as land-based exercise and may have greater benefits with respect to mood and sleep duration. Based on follow-up studies, exercise-induced improvements in physical function, pain and mood may persist for up to 2 years. Pool exercise may be better tolerated as an initial means of exercise by individuals with arthritis in weight-bearing joints (because of water buoyancy) or by individuals who fear exercise will exacerbate their pain.
SUMMARY: Pool exercise can be an effective intervention for individuals with fibromyalgia. Future studies should reassess subjects at multiple time points to determine the time course of exercise-induced improvements and further explore the effects of pool exercise on mood and sleep quality.

Entities:  

Mesh:

Year:  2007        PMID: 17278933     DOI: 10.1097/BOR.0b013e3280327944

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

Review 1.  Aerobic exercise in fibromyalgia: a practical review.

Authors:  Eric N Thomas; Francis Blotman
Journal:  Rheumatol Int       Date:  2010-03-26       Impact factor: 2.631

Review 2.  [Fibromyalgia].

Authors:  M Späth
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

3.  Effects of different protocols of physical exercise on fibromyalgia syndrome treatment: systematic review and meta-analysis of randomized controlled trials.

Authors:  Maria Luiza L Albuquerque; Diogo Monteiro; Daniel A Marinho; Guilherme T Vilarino; Alexandro Andrade; Henrique P Neiva
Journal:  Rheumatol Int       Date:  2022-05-23       Impact factor: 3.580

Review 4.  Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Winfried Häuser; Petra Klose; Jost Langhorst; Babak Moradi; Mario Steinbach; Marcus Schiltenwolf; Angela Busch
Journal:  Arthritis Res Ther       Date:  2010-05-10       Impact factor: 5.156

5.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

6.  Effectiveness of aquatic therapy in the treatment of fibromyalgia syndrome: a randomized controlled open study.

Authors:  Deniz Evcik; Ilknur Yigit; Hasan Pusak; Vural Kavuncu
Journal:  Rheumatol Int       Date:  2008-02-16       Impact factor: 2.631

7.  Spatial-temporal parameters of gait in women with fibromyalgia.

Authors:  José María Heredia Jiménez; Virginia A Aparicio García-Molina; Jesús M Porres Foulquie; Manuel Delgado Fernández; Victor M Soto Hermoso
Journal:  Clin Rheumatol       Date:  2009-01-24       Impact factor: 2.980

8.  A mechanism-based approach to prevention of and therapy for fibromyalgia.

Authors:  Charles J Vierck
Journal:  Pain Res Treat       Date:  2011-10-02

Review 9.  The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review.

Authors:  Joseph G McVeigh; Helen McGaughey; Melissa Hall; Patricia Kane
Journal:  Rheumatol Int       Date:  2008-08-27       Impact factor: 3.580

Review 10.  A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome.

Authors:  Romy Lauche; Holger Cramer; Winfried Häuser; Gustav Dobos; Jost Langhorst
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.